Inhibitory cardiac transcription factor, SRF-N, is generated by caspase 3 cleavage in human heart failure and

Jiang Chang1, Lei Wei, Takayuki Otani

  • 1Department of Molecular and Cellular Biology, Center for Cardiovascular Development, Methodist Hospital, Baylor College of Medicine, One Baylor Plaza, Houston, Tex 77030, USA.

Circulation
|July 23, 2003
PubMed

Insights

In heart failure, caspase 3 cleaves serum response factor (SRF), creating a dominant-negative factor that suppresses cardiac genes. This SRF cleavage may be reversible with ventricular unloading.

Area of Science:

  • Molecular biology
  • Cardiovascular research
  • Biochemistry

Background:

  • Heart failure is characterized by reduced gene activity and modest caspase 3 activation.
  • The role of the cardiac transcription factor serum response factor (SRF) in heart failure is not fully understood.
  • We hypothesized that caspase 3 cleaves SRF, inhibiting its function and contributing to heart failure.

Purpose of the Study:

  • To investigate whether serum response factor (SRF) is a cleavage target of caspase 3 in end-stage heart failure.
  • To determine the functional consequences of SRF cleavage in the failing heart.

Main Methods:

  • Analysis of SRF protein levels and fragmentation in human cardiac samples from heart failure patients and normal controls.
  • Investigation of SRF fragmentation in patients with left ventricular assist devices.
  • Identification of caspase 3 cleavage sites on SRF using antibodies and site-directed mutagenesis.
  • Assessment of the transcriptional activity of SRF fragments in myogenic cells.

Main Results:

  • Full-length SRF was significantly reduced and fragmented in failing hearts but intact in normal hearts.
  • Minimal SRF fragmentation was observed in hearts with left ventricular assist devices.
  • Two alternative caspase 3 cleavage sites were identified, generating N-terminal and C-terminal SRF fragments.
  • Expression of the 32-kDa N-terminal SRF fragment (SRF-N) inhibited alpha-actin gene promoter activity by 50-60%.

Conclusions:

  • Caspase 3 activation in heart failure sequentially cleaves SRF, producing a dominant-negative transcription factor.
  • This process may explain the downregulation of cardiac-specific genes in heart failure.
  • Caspase 3 activation and subsequent SRF cleavage might be reversible upon ventricular unloading.
Abstract

Related Concept Videos

Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...